On Monday, May 18th November from 11:00 am to 11:30 am, ISPOR attendees are invited to our inaugural 'fireside chat' about JCA with health economists, counterparts and SIBLINGS - Dawn Lee and Mark Fisher, hosted by Karl Freemyer.
Dawn is a health economic modeller who has conducted over 50 UK Health Technology Assessment submissions and worked in over 30 countries globally. Mark has conducted over 100 health economics and outcomes research projects and led more than 50 pricing and reimbursement submissions across Europe, North and South America, Asia and Australasia.
Come and hear Mark and Dawn discuss their insights on JCA, the topic which will be dominating the discussion in Barcelona.
Whether you're considering self-funded launches or out-licensing, our model provides comprehensive simulations of potential benefits, enhancing your strategic decision-making process in commercialization.
What is JCA? Is my product eligible? The Joint Clinical Assessment (JCA) for oncology, haematology, and ATMPs will be eligible for assessment from January 12th, 2025 with two significant updates this month.
We offer an advanced value communication tool that allows you to dynamically create custom scenarios, maximizes the efficiency and guarantees highly engaging meetings with the payers.
We offer an advanced value communication tool that allows you to dynamically create custom scenarios, maximizes the efficiency and guarantees highly engaging meetings with the payers.
Input top line project details and select the deliverable of interest and you'll receive a ballpark quote immediately, no commitment necessary! Our RFP Builder is the dawn of a new era in HEOR pricing transparency
We provide fast, flexible, and affordable solutions by asking open-ended questions based on the critique of clinical trial programs and economic models.
We had a team of FIECON experts available to discuss our products and services at stand #1201 in the main exhibition hall.
Mark Fisher
Chief Operating Officer
Talk to Mark about:
HEOR
HTA
Market Access
Karl Freemyer
Head of Business Development
Talk to Karl about:
AI-assisted SLRs
Digital Modelling Dashboards
PICOs Prediction for Joint Clinical Assessment
Susan Suponcic
Strategic Council member
Talk to Susan about:
US and Global Product Launch Strategy
Strategic and Tactical Pricing Initiatives
Portfolio Investment Optimisation
Richard Tolley
Head of Client Partnerships
Talk to Richard about:
Pricing, Reimbursement and Market Access solutions
Value Assessment and Communication
Payer Evidence Strategy
Andrew Revel
Director of Business Development
Talk to Andrew about:
HEOR and Market Access Solutions
Partnership Strategies
Early Value Assessment of Assets
Lawrence Murphy
Director of Business Development
Talk to Lawrence about:
HTA submissions
Early Value Assessments
Joint Clinical Assessment (JCA)
Sabine Gaugris
Executive Director
Talk to Sabine about:
HTA submissions
HEOR and HTA strategy
Joint Clinical Assessment (JCA)
Lisa Cox
Executive Director
Talk to Lisa about:
HTA Strategy
HEOR Strategy
Submission Strategy Advice
Our Research & Posters
We will be presenting on 7 research topics this year, including a an assessment of the application of the NICE Severity Modifier and determining precedents for decision-making and acceptability of evidence in completed National Institute of Health and Care Excellence (NICE) highly specialised technology (HST) appraisals.
Poster presenters will be available in person to talk about their research conclusions during the discussion periods.
Poster Session 1
Date: Monday, 18th November
Poster session time: 10:30AM-1:30PM
Discussion period: 12:30PM-1:30PM
EE144: The Budget Impact of Cangrelor for the Treatment of Patients with Gastric Absorption Issues Undergoing Percutaneous Coronary Intervention in the UK.
HTA119: Assessing a potential framework to prioritise generalised cost-effectiveness analysis (GCEA) value elements in future decision-making by evidence and relevance: case study across oncology and infectious diseases.
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in our marketing efforts. More info
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in our marketing efforts.
